Abstract
The high mortality rate of melanoma is broadly associated with its metastatic potential. Tumor cell dissemination is strictly dependent on vascularization; therefore, angiogenesis and lymphangiogenesis play an essential role in metastasis. Hence, a better understanding of the players of tumor vascularization and establishing them as new molecular biomarkers might help to overcome the poor prognosis of melanoma patients. Here, we further characterized a linear murine model of melanoma progression and showed that the aggressiveness of melanoma cells is closely associated with high expression of angiogenic factors, such as Vegfc, Angpt2, and Six1, and that blockade of the vascular endothelial growth factor pathway by the inhibitor axitinib abrogates their tumorigenic potential in vitro and in the in vivo chicken chorioallantoic membrane assay. Furthermore, analysis of The Cancer Genome Atlas data revealed that the expression of the angiogenic factor ANGPT2 (P‐value = 0.044) and the lymphangiogenic receptor VEGFR‐3 (P‐value = 0.002) were independent prognostic factors of overall survival in melanoma patients. Enhanced reduced representation bisulfite sequencing‐based methylome profiling revealed for the first time a link between abnormal VEGFC, ANGPT2, and SIX1 gene expression and promoter hypomethylation in melanoma cells. In patients, VEGFC (P‐value = 0.031), ANGPT2 (P‐value < 0.001), and SIX1 (P‐value = 0.009) promoter hypomethylation were independent prognostic factors of shorter overall survival. Hence, our data suggest that these angio‐ and lymphangiogenesis factors are potential biomarkers of melanoma prognosis. Moreover, these findings strongly support the applicability of our melanoma progression model to unravel new biomarkers for this aggressive human disease.
Highlights
Melanoma mortality rate, one of the highest among all human cancers, is broadly associated with its metastatic potential (Tımar et al, 2016)
4C11À and 4C11+ cells were engrafted onto the chorioallantoic membrane (CAM) and incubated for 3–5 days. 4C11- tumors grew at a slow rate, with only a small tumor mass being visible at day 3
In String analysis, we found that VEGFC, ANGPT2, MET, and SHC4 proteins interact, which is a further support of their possible role in the 4C11+ cells aggressive phenotype
Summary
One of the highest among all human cancers, is broadly associated with its metastatic potential (Tımar et al, 2016). Melanoma cells produce several proangiogenic factors, including vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), placental growth factor (PDGF), and angiopoietin (ANGPT), which are involved in tumor vascularization (Matsumoto and Claesson-Welsh, 2001). One of the major players is the VEGF family, which is comprised of the glycoproteins VEGFA, VEGFB, VEGFC, VEGFD, and PDGF, and their tyrosine kinase receptors vascular endothelial growth factor receptor (VEGFR)-1 (FLT1), VEGFR-2 (KDR), VEGFR-3 (FLT4), and co-receptor NRP. Cutaneous melanomas have a high metastatic potential to lymph nodes, which is associated with high expression of VEGFC (Adler et al, 2017; Boone et al, 2008)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
